Free Trial

Palvella Therapeutics (PVLA) SEC Filings & 10K Form

Palvella Therapeutics logo
$23.98 -0.45 (-1.84%)
As of 04/4/2025 04:00 PM Eastern

Recent Palvella Therapeutics SEC Filings

DateFilerForm TypeView
03/31/2025
6:51 AM
PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/31/2025
6:32 AM
PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
7:00 AM
PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
5:25 PM
Kaupinen Wes (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4/A
02/10/2025
4:40 PM
Goin Kathleen (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4/A
02/10/2025
5:00 PM
Martini Jeffrey S (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4/A
02/10/2025
4:21 PM
Korenberg Matthew E (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4/A
02/07/2025
3:29 PM
PALVELLA THERAPEUTICS, INC. (Reporting)
Palvella Therapeutics (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:29 PM
PALVELLA THERAPEUTICS, INC. (Reporting)
Palvella Therapeutics (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:30 PM
PALVELLA THERAPEUTICS, INC. (Reporting)
Palvella Therapeutics (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:30 PM
PALVELLA THERAPEUTICS, INC. (Reporting)
Palvella Therapeutics (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
11:15 PM
PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
Form EFFECT
01/14/2025
5:22 AM
PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
Form S-1/A
01/13/2025
6:00 AM
PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
2:04 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
Form SCHEDULE 13G
12/31/2024
5:04 AM
PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/20/2024
4:32 PM
Kaupinen Wes (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
Form SCHEDULE 13D
12/20/2024
3:56 PM
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SCHEDULE 13G
12/20/2024
3:59 PM
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
Form SCHEDULE 13G
12/19/2024
9:23 AM
JENKINS GEORGE M (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:45 PM
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Wessel Tadd S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:46 PM
HERON ELAINE J (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:40 PM
KIRITSY CHRISTOPHER P (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:41 PM
Kaupinen Wes (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:42 PM
JENKINS GEORGE M (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:43 PM
Korenberg Matthew E (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:43 PM
Goin Kathleen (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:44 PM
Martini Jeffrey S (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:44 PM
Davis Todd C (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:42 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
Form SC 13G/A
12/17/2024
4:44 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:22 PM
Dellora Investments LP (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
Form SCHEDULE 13G/A
12/16/2024
6:40 PM
HERON ELAINE J (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
6:41 PM
Davis Todd C (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
6:41 PM
JENKINS GEORGE M (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
6:42 PM
Martini Jeffrey S (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
6:43 PM
Goin Kathleen (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
6:43 PM
Kaupinen Wes (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
6:44 PM
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Wessel Tadd S. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
6:44 PM
Korenberg Matthew E (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
3:18 PM
Dellora Investments LP (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Feds Just Admitted It—They Can Take Your Cash (Ad)

The Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money isn't legally yours. Now, think your savings are safe? Think again.

Click here to get the 3 secret strategies you can put in place starting today
12/13/2024
8:53 PM
PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
3:15 PM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
3:15 PM
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
Form 425
12/12/2024
3:16 PM
GERAGHTY JAMES A (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
6:32 AM
KIRITSY CHRISTOPHER P (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
1:21 PM
Dellora Investments LP (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
Form SCHEDULE 13G/A
12/03/2024
7:30 AM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
7:30 AM
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
Form 425
11/18/2024
3:16 PM
Dellora Investments LP (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/14/2024
8:07 AM
Lynx1 Capital Management LP (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
Form SC 13G/A
11/13/2024
3:02 PM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
8:01 AM
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
Form 425
11/07/2024
7:47 AM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form S-4/A
11/06/2024
4:00 PM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form ARS
11/06/2024
4:01 PM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form DEF 14A
11/05/2024
4:01 PM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form S-4/A
10/29/2024
7:45 AM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form S-4/A
10/28/2024
4:18 PM
GERAGHTY JAMES A (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
7:00 AM
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
Form 425
10/15/2024
7:30 AM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form S-4/A
10/15/2024
7:00 AM
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
Form 425
10/03/2024
7:00 AM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
7:00 AM
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
Form 425
09/23/2024
5:15 AM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form S-4/A
08/12/2024
5:48 PM
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
4:29 PM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
08/07/2024
1:16 PM
Dellora Investments LP (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
Form SCHEDULE 13G
08/01/2024
7:00 AM
ADAR1 Capital Management, LLC (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
Form SC 13G
07/31/2024
6:26 PM
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/24/2024
5:40 AM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
5:40 AM
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
Form 425
07/03/2024
3:32 PM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:00 AM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
3:21 PM
PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:PVLA) was last updated on 4/5/2025 by MarketBeat.com Staff
From Our Partners